• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cutting Edge: Enhanced Antitumor Immunity in ST8Sia6 Knockout Mice.前沿:ST8Sia6 敲除小鼠增强的抗肿瘤免疫。
J Immunol. 2022 Apr 15;208(8):1845-1850. doi: 10.4049/jimmunol.2101165. Epub 2022 Apr 4.
2
ST8Sia6 Promotes Tumor Growth in Mice by Inhibiting Immune Responses.ST8Sia6 通过抑制免疫应答促进小鼠肿瘤生长。
Cancer Immunol Res. 2021 Aug;9(8):952-966. doi: 10.1158/2326-6066.CIR-20-0834. Epub 2021 Jun 1.
3
Cutting Edge: ST8Sia6-Generated α-2,8-Disialic Acids Mitigate Hyperglycemia in Multiple Low-Dose Streptozotocin-Induced Diabetes.前沿:ST8Sia6 生成的 α-2,8-二唾液酸减轻多次低剂量链脲佐菌素诱导的糖尿病的高血糖。
J Immunol. 2020 Jun 15;204(12):3071-3076. doi: 10.4049/jimmunol.2000023. Epub 2020 Apr 29.
4
Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer.靶向唾液酸 - Siglec 相互作用以逆转癌症中的免疫抑制。
Glycobiology. 2018 Sep 1;28(9):640-647. doi: 10.1093/glycob/cwx108.
5
Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions.通过 Siglec-唾液酸相互作用调节免疫耐受。
Front Immunol. 2018 Dec 7;9:2807. doi: 10.3389/fimmu.2018.02807. eCollection 2018.
6
Increased alpha2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells.耐受性未成熟树突状细胞和调节性T细胞表面蛋白的α2,6-唾液酸化增加。
Exp Hematol. 2006 Sep;34(9):1212-8. doi: 10.1016/j.exphem.2006.04.016.
7
B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.B 细胞信号识别分子——信号转导及其与配体结合的最新研究进展。
Front Immunol. 2018 Dec 3;9:2820. doi: 10.3389/fimmu.2018.02820. eCollection 2018.
8
Possible Influences of Endogenous and Exogenous Ligands on the Evolution of Human Siglecs.内源性和外源性配体对人类 Siglecs 进化的可能影响。
Front Immunol. 2018 Dec 4;9:2885. doi: 10.3389/fimmu.2018.02885. eCollection 2018.
9
LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.长链非编码 RNA ST8SIA6-AS1 通过 p38 MAPK 信号通路促进乳腺癌的增殖、迁移和侵袭。
Carcinogenesis. 2020 Sep 24;41(9):1273-1281. doi: 10.1093/carcin/bgz197.
10
The α2,8-sialyltransferase 6 (St8sia6) localizes in the ER and enhances the anchorage-independent cell growth in cancer.α2,8-唾液酸转移酶 6(St8sia6)定位于内质网,增强癌症的非锚定依赖性细胞生长。
Biochem Biophys Res Commun. 2022 Jun 11;608:52-58. doi: 10.1016/j.bbrc.2022.03.146. Epub 2022 Mar 28.

引用本文的文献

1
Tumor desialylation surpasses anti-PD-L1 checkpoint therapy in restoring anti-tumor immunity in a murine model for colorectal cancer.在结直肠癌小鼠模型中,肿瘤去唾液酸化在恢复抗肿瘤免疫方面优于抗PD-L1检查点疗法。
Int J Cancer. 2025 Nov 1;157(9):1948-1962. doi: 10.1002/ijc.70031. Epub 2025 Jul 7.
2
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade.靶向肿瘤糖基化重编程肿瘤相关巨噬细胞,从而实现有效的免疫检查点阻断。
Sci Transl Med. 2022 Nov 2;14(669):eabj1270. doi: 10.1126/scitranslmed.abj1270.

本文引用的文献

1
Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response.调节肿瘤浸润髓系细胞以增强双特异性抗体驱动的 T 细胞浸润和抗肿瘤反应。
J Hematol Oncol. 2021 Sep 8;14(1):142. doi: 10.1186/s13045-021-01156-5.
2
ST8Sia6 Promotes Tumor Growth in Mice by Inhibiting Immune Responses.ST8Sia6 通过抑制免疫应答促进小鼠肿瘤生长。
Cancer Immunol Res. 2021 Aug;9(8):952-966. doi: 10.1158/2326-6066.CIR-20-0834. Epub 2021 Jun 1.
3
Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation.Siglec-E 通过抑制 CD36 介导的泡沫细胞形成来延缓动脉粥样硬化。
J Biomed Sci. 2021 Jan 5;28(1):5. doi: 10.1186/s12929-020-00698-z.
4
Cutting Edge: ST8Sia6-Generated α-2,8-Disialic Acids Mitigate Hyperglycemia in Multiple Low-Dose Streptozotocin-Induced Diabetes.前沿:ST8Sia6 生成的 α-2,8-二唾液酸减轻多次低剂量链脲佐菌素诱导的糖尿病的高血糖。
J Immunol. 2020 Jun 15;204(12):3071-3076. doi: 10.4049/jimmunol.2000023. Epub 2020 Apr 29.
5
Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity.CD40 激活和免疫检查点阻断对 T 细胞启动和肿瘤免疫的充分性。
Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):8022-8031. doi: 10.1073/pnas.1918971117. Epub 2020 Mar 25.
6
Tumor-associated macrophages: an accomplice in solid tumor progression.肿瘤相关巨噬细胞:实体瘤进展的帮凶。
J Biomed Sci. 2019 Oct 20;26(1):78. doi: 10.1186/s12929-019-0568-z.
7
Immune checkpoint inhibitor-induced diarrhea/colitis: Endoscopic and pathologic findings.免疫检查点抑制剂诱发的腹泻/结肠炎:内镜及病理表现
World J Gastrointest Pathophysiol. 2019 Sep 10;10(2):17-28. doi: 10.4291/wjgp.v10.i2.17.
8
Diabetes mellitus secondary to treatment with immune checkpoint inhibitors.免疫检查点抑制剂治疗继发的糖尿病。
Curr Oncol. 2019 Feb;26(1):e111-e114. doi: 10.3747/co.26.4151. Epub 2019 Feb 1.
9
Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions.通过 Siglec-唾液酸相互作用调节免疫耐受。
Front Immunol. 2018 Dec 7;9:2807. doi: 10.3389/fimmu.2018.02807. eCollection 2018.
10
The Key Role of TNF-TNFR2 Interactions in the Modulation of Allergic Inflammation: A Review.TNF-TNFR2 相互作用在过敏性炎症调节中的关键作用:综述。
Front Immunol. 2018 Nov 9;9:2572. doi: 10.3389/fimmu.2018.02572. eCollection 2018.

前沿:ST8Sia6 敲除小鼠增强的抗肿瘤免疫。

Cutting Edge: Enhanced Antitumor Immunity in ST8Sia6 Knockout Mice.

机构信息

Department of Immunology, Mayo Clinic, Rochester, MN; and.

Department of Urology, College of Medicine, Mayo Clinic, Rochester, MN.

出版信息

J Immunol. 2022 Apr 15;208(8):1845-1850. doi: 10.4049/jimmunol.2101165. Epub 2022 Apr 4.

DOI:10.4049/jimmunol.2101165
PMID:35379746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9012686/
Abstract

Inhibitory receptors have a critical role in the regulation of immunity. Siglecs are a family of primarily inhibitory receptors expressed by immune cells that recognize specific sialic acid modifications on cell surface glycans. Many tumors have increased sialic acid incorporation. Overexpression of the sialyltransferase ST8Sia6 on tumors led to altered immune responses and increased tumor growth. In this study, we examined the role of ST8Sia6 on immune cells in regulating antitumor immunity. ST8Sia6 knockout mice had an enhanced immune response to tumors. The loss of ST8Sia6 promoted an enhanced intratumoral activation of macrophages and dendritic cells, including upregulation of CD40. Intratumoral regulatory T cells exhibited a more inflammatory phenotype in ST8Sia6 knockout mice. Using adoptive transfer studies, the change in regulatory T cell phenotype was not cell intrinsic and depended on the loss of ST8Sia6 expression in APCs. Thus, ST8Sia6 generates ligands for Siglecs that dampen antitumor immunity.

摘要

抑制性受体在免疫调节中起着关键作用。Siglecs 是一类主要的抑制性受体,表达于免疫细胞上,能够识别细胞表面糖链上特定的唾液酸修饰。许多肿瘤中唾液酸的含量增加。肿瘤中唾液酸转移酶 ST8Sia6 的过度表达导致免疫反应改变和肿瘤生长增加。在这项研究中,我们研究了 ST8Sia6 对免疫细胞在调节抗肿瘤免疫中的作用。ST8Sia6 敲除小鼠对肿瘤的免疫反应增强。ST8Sia6 的缺失促进了肿瘤内巨噬细胞和树突状细胞的激活,包括 CD40 的上调。肿瘤内调节性 T 细胞在 ST8Sia6 敲除小鼠中表现出更具炎症表型。通过过继转移研究,调节性 T 细胞表型的改变不是细胞内在的,而是依赖于 APC 中 ST8Sia6 表达的缺失。因此,ST8Sia6 产生 Siglec 的配体,从而抑制抗肿瘤免疫。